J 2015

DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients

LORENZO-BETANCOR, O., K. OGAKI, A.I. SOTO-ORTOLAZA, C. LABBE, R.L. WALTON et. al.

Basic information

Original name

DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients

Authors

LORENZO-BETANCOR, O. (840 United States of America), K. OGAKI (840 United States of America), A.I. SOTO-ORTOLAZA (840 United States of America), C. LABBE (840 United States of America), R.L. WALTON (840 United States of America), A.J. STRONGOSKY (840 United States of America), J.A. VAN GERPEN (840 United States of America), R.J. UITTI (840 United States of America), P.J. MCLEAN (840 United States of America), W. SPRINGER (840 United States of America), J. SIUDA (616 Poland), G. OPALA (616 Poland), A. KRYGOWSKA-WAJS (616 Poland), M. BARCIKOWSKA (616 Poland), K. CZYZEWSKI (616 Poland), A. MCCARTHY (372 Ireland), T. LYNCH (372 Ireland), A. PUSCHMANN (752 Sweden), Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution), Y. SANOTSKY (804 Ukraine), C. VILARINO-GUELL (124 Canada), M.J. FARRER (124 Canada), T.J. FERMAN (840 United States of America), B.F. BOEVE (840 United States of America), R.C. PETERSEN (840 United States of America), J.E. PARISI (840 United States of America), N.R. GRAFF-RADFORD (840 United States of America), D.W. DICKSON (840 United States of America), Z.K. WSZOLEK (840 United States of America) and O.A. ROSS (840 United States of America)

Edition

European Journal of Neurology, Hoboken (USA), Wiley-Blackwell, 2015, 1351-5101

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.956

RIV identification code

RIV/00216224:14740/15:00085056

Organization unit

Central European Institute of Technology

UT WoS

000359863000014

Keywords in English

DNAJC13; genetics; Lewy body disease; Parkinson's disease

Tags

Tags

International impact, Reviewed
Změněno: 7/3/2016 15:03, Olga Křížová

Abstract

V originále

BackgroundRecently, a novel mutation in exon 24 of DNAJC13 gene (p.Asn855Ser, rs387907571) has been reported to cause autosomal dominant Parkinson's disease (PD) in a multi-incident Mennonite family. MethodsIn the present study the mutation containing exon of the DNAJC13 gene has been sequenced in a Caucasian series consisting of 1938 patients with clinical PD and 838 with pathologically diagnosed Lewy body disease (LBD). ResultsOur sequence analysis did not identify any coding variants in exon 24 of DNAJC13. Two previously described variants in intron 23 (rs200204728 and rs2369796) were observed. ConclusionOur results indicate that the region surrounding the DNAJC13 p.Asn855Ser substitution is highly conserved and mutations in this exon are not a common cause of PD or LBD among Caucasian populations.

Files attached

1319703_DNAJC13_p.Asn855Ser.pdf
Request the author's version of the file
ZVV_2015_141_1319703_DNAJC13.pdf
Request the author's version of the file